GNH USA

Europe — EMA

Montelukast Mabo

GNH USA supplies Montelukast Mabo (Montelukast), a leukotriene receptor antagonist for asthma maintenance and allergic rhinitis. Request a quote for supply.

Montelukast

Request sourcing

1
Pack/s

What is Montelukast?

Montelukast, the active ingredient in Montelukast Mabo, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is employed to control chronic asthma and to relieve symptoms of allergic rhinitis in adults and children.

GNH USA supplies Montelukast Mabo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. It offers comprehensive regulatory support and ensures timely delivery to meet client needs.

What is Montelukast used for?

Montelukast acts on the leukotriene pathway to manage several allergic and respiratory conditions. - Asthma: improves long‑term control and reduces the frequency of bronchospasm episodes. - Allergic rhinitis: alleviates nasal congestion, sneezing and itching. - Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.

What are the side effects of Montelukast?

Montelukast may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often transient. - Abdominal pain: discomfort in the stomach area. - Cough: occasional dry cough. - Nausea: feeling of queasiness. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Allergic reactions: rash, urticaria, or angioedema. - Mood changes: depression, anxiety, or suicidal thoughts. - Hepatic enzyme elevation: increased liver transaminases. - Stevens‑Johnson syndrome: severe skin blistering.

What precautions apply to Montelukast?

Before prescribing Montelukast, consider the following safety measures. - Liver monitoring: assess hepatic function in patients with liver disease. - Neuropsychiatric assessment: watch for mood swings, depression, or suicidal ideation. - Hypersensitivity: avoid use in individuals with known allergy to montelukast. - Drug interactions: review concomitant medications that may induce hepatic enzymes. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

What does Montelukast interact with?

Montelukast can interact with other medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Rifampin: strong enzyme inducer reduces montelukast plasma levels. - Phenobarbital: induces metabolism, decreasing efficacy. - Carbamazepine: increases clearance, potentially lowering therapeutic effect.

Moderate Interactions (Monitor Closely): - Fluconazole: moderate CYP3A4 inhibition may raise montelukast concentrations. - Ketoconazole: similar inhibition effect requiring observation. - Zidovudine: may increase risk of hepatic toxicity.

Frequently asked questions

What is Montelukast Mabo used for?+
Montelukast Mabo contains the active substance montelukast, a leukotriene receptor antagonist indicated for the maintenance treatment of asthma and for relief of symptoms associated with seasonal or perennial allergic rhinitis. It may also be prescribed to prevent exercise‑induced bronchoconstriction in patients who experience airway narrowing during physical activity. The medication is taken orally under the direction of a qualified healthcare professional.
How does montelukast work?+
Montelukast works by selectively binding to the cysteinyl leukotriene receptor CysLT1, blocking the action of leukotriene D4 and related mediators. This inhibition prevents bronchoconstriction, reduces vascular permeability, and limits the recruitment of inflammatory cells in the respiratory tract, thereby improving airflow and decreasing allergic inflammation. The effect is achieved with once‑daily oral dosing.
What is the usual dose of Montelukast Mabo?+
The appropriate dose of Montelukast Mabo is determined by the prescribing clinician based on the patient’s age, weight, severity of disease, and overall health status. Dosage recommendations differ for asthma maintenance, allergic rhinitis, and exercise‑induced bronchoconstriction, and the medication should be taken exactly as instructed on the prescription label.
Is Montelukast safe during pregnancy or breastfeeding?+
The safety of montelukast in pregnancy has not been definitively established, and it is classified as a pregnancy category with limited data. Women who are pregnant or planning to become pregnant should discuss potential risks and benefits with their healthcare provider. Montelukast is excreted in breast milk, so nursing mothers should also seek medical advice before use.
How do I order Montelukast Mabo from GNH USA?+
To request Montelukast Mabo, visit the product page on gnh-usa.com and submit an enquiry specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details—including any required temperature control—and assists with import documentation.
How does Montelukast compare with inhaled corticosteroids?+
Montelukast belongs to a different therapeutic class than inhaled corticosteroids (ICS). While ICS directly suppress airway inflammation, montelukast blocks leukotriene‑mediated pathways and is often used as an add‑on therapy or for patients who cannot tolerate steroids. Clinical guidelines suggest montelukast may be less effective than high‑dose ICS for severe asthma, but it offers the convenience of oral administration and can improve control in certain phenotypes.
What are the storage requirements for Montelukast Mabo?+
Montelukast Mabo should be stored at room temperature, preferably below 25 °C (77 °F). Keep the tablets in their original blister pack or container to protect them from moisture and light. Do not store in areas with high humidity or extreme heat, and keep out of reach of children. No refrigeration is required.
How is Montelukast administered?+
Montelukast is taken orally, usually as a tablet swallowed whole with water. The medication is typically taken once daily in the evening, but the exact timing and frequency are determined by the prescribing physician. Patients should follow the label instructions and not crush or chew the tablet unless specifically directed. Consistent daily use is important for optimal therapeutic effect.
What are the most serious risks associated with Montelukast?+
Although generally well tolerated, montelukast carries a risk of serious adverse events. These include severe allergic reactions such as rash, urticaria, or angioedema, and neuropsychiatric effects like depression, anxiety, or suicidal thoughts. Rarely, hepatic injury or severe skin conditions such as Stevens‑Johnson syndrome may occur. Patients should seek immediate medical attention if they experience any of these symptoms.
Who should not use Montelukast?+
Montelukast is contraindicated in individuals with a known hypersensitivity to the drug or any of its excipients. It should be used with caution in patients with existing liver disease, severe psychiatric disorders, or a history of serious allergic reactions. Pregnant or nursing women, as well as children under the approved age for specific indications, must only use the medication under direct medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Montelukast
Route
Oral Use
Manufacturer
Mabo-Farma, S.A
Origin
EU

Related products

MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA